A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma

NARecruitingINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

September 2, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Midface Volume Deficit
Interventions
DEVICE

Decoria Voluma

"Decoria® Voluma medical device is a sterile, single use Hyaloronic acid based dermal filler intended for aesthetic use, provided in the form of a nonpyrogenic, viscoelastic gel. It is composed of highly purified sodium hyaluronate of high molecular weight, dissolved in a physiological buffer at pH 6.0-7.5. The sodium hyaluronate is derived from microbial fermentation and is stabilized by crosslinking with the chemical agent BDDE (1,4 Butanediol Diglycidyl Ether).~Decoria® Voluma dermal fillers are injected into dermal tissue for the correction of midface volume deficit by tissue augmentation in cheek region, supporting overlying tissue to shape facial contours to desired level of correction. This is possible due to the capacity of HA to attract and bind large amounts of water, forming a viscous gel.~Appropriate injection volume for the cheek region(s) will be determined by the Treating investigator according to IFU."

Trial Locations (7)

411 07

RECRUITING

Inskinity, Gothenburg

411 08

NOT_YET_RECRUITING

Göteborgs Laser & Estetik, Gothenburg

652 25

RECRUITING

Svenska Hudkliniker, Karlstad

111 28

RECRUITING

Inskinity, Stockholm

113 28

RECRUITING

Florakliniken, Stockholm

114 46

RECRUITING

The Faculty, Stockholm

Unknown

RECRUITING

Svenska Hudkliniker, Stockholm

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Key2Compliance

INDUSTRY

lead

Bohus Biotech AB

INDUSTRY